Physician

Robert H Lewe, MD

According to 2025 Medicare claims, Robert Lewe, MD (NPI: 1649387226) practices urology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Christian, KY. This provider's primary affiliated billing organization is JENNIE STUART MEDICAL CENTER INC (NPI: 1588384671; TIN: 61-0482973) and primary practice location at 42240-6300. Lewe is affiliated with the Imperium Clinical Partners (ACO ID: A4945), participating under the MSSP model.

Lewe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 508 traditional Medicare patients, billed 1,191 HCPCS/CPT codes, and received $74,833 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,908 prescription claims across 665 beneficiaries totaling $378,298 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 22 claims. Open Payments data shows 18 records totaling $996. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $112,749 to $74,833. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $192,297 and ending at $378,298. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	489	2,177	$112,749
2016	492	1,931	$102,259
2017	558	2,576	$147,091
2018	588	4,388	$214,278
2019	349	1,518	$79,562
2020	404	1,271	$86,141
2021	427	1,114	$80,024
2022	406	927	$73,286
2023	491	1,106	$72,202
2024	508	1,191	$74,833

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	344	2,723	$192,297
2016	343	2,599	$151,574
2017	456	2,968	$193,513
2018	507	4,029	$290,321
2019	403	2,288	$154,079
2020	340	1,440	$88,326
2021	353	1,943	$145,552
2022	405	2,237	$205,418
2023	546	2,874	$340,532
2024	665	3,908	$378,298

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$5,664
2016	N/R	96	$6,982
2017	N/R	32	$6,222
2018	N/R	35	$10,463
2019	N/R	33	$8,315
2020	N/R	24	$5,124
2021	N/R	16	$3,790
2022	N/R	12	$6,159
2023	N/R	16	$6,301
2024	N/R	22	$14,709

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	102	102	$84
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	199	300	$68
52000	Diagnostic exam of bladder and urethra using an endoscope	52	56	$57
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	342	481	$42
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	34	40	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	240	10,955	$165,115
Gemtesa	Vibegron	152	8,158	$129,395
Tamsulosin Hcl	Tamsulosin Hcl	1,148	69,081	$18,122
Solifenacin Succinate	Solifenacin Succinate	180	8,859	$12,803
Finasteride	Finasteride	808	63,705	$9,420

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	22	$14,709

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$996	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert H. Lewe, MD?

Tedicare shows public-source Medicare data for Robert H. Lewe, MD (NPI 1649387226), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert H. Lewe, MD have ACO affiliation data?

Robert H. Lewe, MD is shown with ACO affiliation data for Imperium Clinical Partners (MSSP, ACO ID A4945).

What billing organization is linked to Robert H. Lewe, MD?

Robert H. Lewe, MD is linked to JENNIE STUART MEDICAL CENTER INC (billing NPI 1588384671) in the available physician profile data.

Does Robert H. Lewe, MD have Open Payments data?

Robert H. Lewe, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.